Literature DB >> 25899710

Transparency in Research involving Animals: The Basel Declaration and new principles for reporting research in BJP manuscripts.

John C McGrath1, Elspeth M McLachlan, Rolf Zeller.   

Abstract

This article discusses the background to the need for change in the reporting of experiments involving animals, including a report of a consensus meeting organised by the Basel Declaration Society and Understanding Animal Research UK that sought to Internationalise guidelines for reporting experiments involving animals. A commentary on the evolution of BJP's attempts to implement the ARRIVE guidelines and details of our new guidance for authors is published separately (McGrath, 2014). This is one of a series of editorials discussing updates to the BJP Instructions to Authors LINKED EDITORIALS: This Editorial is the first in a series. The other Editorials in this series will be published in the forthcoming issues. To view them, visit: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381.
© 2015 The British Pharmacological Society.

Entities:  

Mesh:

Year:  2015        PMID: 25899710      PMCID: PMC4409896          DOI: 10.1111/bph.12956

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines.

Authors:  J C McGrath; G B Drummond; E M McLachlan; C Kilkenny; C L Wainwright
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Authors:  Carol Kilkenny; William Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP.

Authors:  John C McGrath; Elliot Lilley
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

4.  Improving planning, design, reporting and scientific quality of animal experiments by using the Gold Standard Publication Checklist, in addition to the ARRIVE guidelines.

Authors:  Carlijn R Hooijmans; Rob de Vries; Marlies Leenaars; Jo Curfs; Merel Ritskes-Hoitinga
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

5.  The Rat Genome Database 2015: genomic, phenotypic and environmental variations and disease.

Authors:  Mary Shimoyama; Jeff De Pons; G Thomas Hayman; Stanley J F Laulederkind; Weisong Liu; Rajni Nigam; Victoria Petri; Jennifer R Smith; Marek Tutaj; Shur-Jen Wang; Elizabeth Worthey; Melinda Dwinell; Howard Jacob
Journal:  Nucleic Acids Res       Date:  2014-10-29       Impact factor: 19.160

  5 in total
  25 in total

1.  Experimental design and analysis and their reporting: new guidance for publication in BJP.

Authors:  Michael J Curtis; Richard A Bond; Domenico Spina; Amrita Ahluwalia; Stephen P A Alexander; Mark A Giembycz; Annette Gilchrist; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Andrew J Lawrence; David J MacEwan; Lawrence D F Moon; Sue Wonnacott; Arthur H Weston; John C McGrath
Journal:  Br J Pharmacol       Date:  2015-07       Impact factor: 8.739

2.  Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP.

Authors:  John C McGrath; Elliot Lilley
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

3.  Updating the guidelines for data transparency in the British Journal of Pharmacology - data sharing and the use of scatter plots instead of bar charts.

Authors:  Christopher H George; S Clare Stanford; Steve Alexander; Giuseppe Cirino; James R Docherty; Mark A Giembycz; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Yong Ji; David J MacEwan; Christopher G Sobey; Sue Wonnacott; Amrita Ahluwalia
Journal:  Br J Pharmacol       Date:  2017-09       Impact factor: 8.739

4.  Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology.

Authors:  Steve P H Alexander; Richard E Roberts; Brad R S Broughton; Christopher G Sobey; Christopher H George; S Clare Stanford; Giuseppe Cirino; James R Docherty; Mark A Giembycz; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Yong Ji; David J MacEwan; Jonathan Mangum; Sue Wonnacott; Amrita Ahluwalia
Journal:  Br J Pharmacol       Date:  2018-02       Impact factor: 8.739

5.  Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway.

Authors:  M García-Caballero; S Blacher; J Paupert; A R Quesada; M A Medina; A Noël
Journal:  Br J Pharmacol       Date:  2016-05-04       Impact factor: 8.739

6.  COX-2 Inhibition Antagonizes Intra-Accumbens 2-Arachidonoylglycerol-Mediated Reduction in Ethanol Self-Administration in Rats.

Authors:  Francisco J Pavon; Ilham Polis; David G Stouffer; Marisa Roberto; Rémi Martin-Fardon; Fernando Rodriguez de Fonseca; Loren H Parsons; Antonia Serrano
Journal:  Alcohol Clin Exp Res       Date:  2020-10-03       Impact factor: 3.455

Review 7.  Tactics for preclinical validation of receptor-binding radiotracers.

Authors:  Susan Z Lever; Kuo-Hsien Fan; John R Lever
Journal:  Nucl Med Biol       Date:  2016-09-03       Impact factor: 2.408

8.  Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1.

Authors:  Jing Chen; Jinsheng Lai; Lei Yang; Guoran Ruan; Sandip Chaugai; Qin Ning; Chen Chen; Dao Wen Wang
Journal:  Br J Pharmacol       Date:  2015-12-25       Impact factor: 8.739

9.  C3a receptor antagonist therapy is protective with or without thrombolysis in murine thromboembolic stroke.

Authors:  Saif Ahmad; Chirayu Pandya; Adam Kindelin; Kanchan Bhatia; Rafay Chaudhary; Alok Kumar Dwivedi; Jennifer M Eschbacher; Qiang Liu; Michael F Waters; Md Nasrul Hoda; Andrew F Ducruet
Journal:  Br J Pharmacol       Date:  2020-03-04       Impact factor: 8.739

10.  Cloning and characterization of the rat Slo3 (KCa 5.1) channel: From biophysics to pharmacology.

Authors:  Guang-Ming Wang; Zhi-Gang Zhong; Xiang-Rong Du; Fei-Fei Zhang; Qing Guo; Ye Liu; Qiong-Yao Tang; Zhe Zhang
Journal:  Br J Pharmacol       Date:  2020-05-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.